Local News
    Multimedia
    News Extras
    Photo Galleries
    News to Use
News from AP
    National News
    Entertainment
    Sports
Obituaries
Sports
    SG at the Glen
    Corning Classic
    Elmira Pioneers
    Elmira Jackals
Opinion
Twin Tiers Life
Twin Tiers Business
Columnists
Weather
Updated weekly
So. Finger Lakes
Time Out
    Calendar
    Best Bets
    Dating
    Dining Guide
Social Announcements
Tech featuring e

    
Special Ernie Davis Section - December 8, 2001     

The disease that killed him

Star-Gazette

Ernie Davis suffered from acute monocytic leukemia.

Leukemia is a cancer of the blood-manufacturing tissues of bone marrow. White blood cells take over the bone marrow, making fewer clot-forming platelets. Red blood cells decrease, causing a lack of oxygen.

Today, only one in 100,000 patients develop that form of leukemia, and survival rates are low.

Early symptoms include fatigue, fever, abnormal bruising, swelling of the lymph nodes, joint pain and infections that don't seem to get better. From newspaper accounts, it appears Davis suffered from at least some of those symptoms. Swelling of the glands in his neck prompted a trainer to send him to the hospital.

Today, treatment for AML includes a combination of chemotherapy drugs, nutritional support and antibiotics. Sometimes, a patient receives blood transfusions because the doses of chemotherapy can be very toxic. In some cases, transplants of bone marrow or bone marrow stem cells are required.

The remission rate for adult patients is 70 to 80 percent. If left untreated, life expectancy is three to four months.

Chemotherapy was not very effective in the early 1960s, when Davis was stricken. And a bone marrow transplant would not have been an option.

Davis, treated by Dr. Austin S. Weisberger of Cleveland, received high doses of medication. In his final days, he was heavily sedated with morphine.

Star-Gazette.COM
Copyright © 2005 Star-Gazette. Use of this site signifies your agreement to the Terms of Service (updated 12/19/2002).
Send questions or comments to Webmaster.